Matches in SemOpenAlex for { <https://semopenalex.org/work/W3035227002> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W3035227002 abstract "Nonalcoholic steatohepatitis (NASH) is a progressive liver disease characterized by steatosis and inflammation, which results in fibrosis. In particular, advanced fibrosis due to NASH is associated with a high risk of liver-related mortality, becoming one main cause for liver transplant. To date, there are, however, no pharmacological therapy approved. One major hurdle for the drug development is limited pathologic features of current animal models, in terms of clinical relevance. The choline-deficient and high fat diet (CDHFD) mice have known to develop multiple aspects of NASH and fibrosis similarly with those in human, being increasingly recognized as a feasible disease model. HM15211 is a novel long-acting GLP-1/GIP/Glucagon triple agonist. Previously, HM15211 treatment improved liver fat and fibrosis in various animal models of NASH and fibrosis. Here, we further explored its efficacy in CDHFD mice. In CDHFD mice (8 wks induction), HM15211 significantly reduced hepatic TG and TBARS (oxidative stress marker). Histological analysis indicated a significant reduction both in hepatic inflammatory marker expression and NAFLD activity score. Of note, when compared to FXR agonist or ACC (acetyl CoA carboxylase) inhibitor, HM15211 treatment was associated with greater efficacy improvement. To further confirm, CDHFD mice with an extended induction period (up to 16 wks) was used. Despite the severe disease progression featured by advanced liver fibrosis, HM15211 reduced hepatic hydroxyproline (-42% vs. vehicle) and sirius red positive area (11.9% vs. 4.1% for vehicle and HM15211) markedly in addition to significant liver TG reduction (66.2% vs. vehicle). Therefore, consistent efficacy in various animal models including CDHFD mice suggests the beneficial effect of HM15211 on NASH and fibrosis. Efficacy studies in biopsy proven NASH patients are ongoing to assess the clinical relevance of these findings. Disclosure J. Choi: Employee; Self; Hanmi Pharmaceutical. J. Kim: Employee; Self; Hanmi Pharmaceutical. S. Lee: Employee; Self; Hanmi Pharmaceutical. H. Kwon: Employee; Self; Hanmi Pharmaceutical. J. Lee: Employee; Self; Hanmi Pharmaceutical. S. Bae: Employee; Self; Hanmi Pharmaceutical. D. Kim: Board Member; Self; Hanmi Pharmaceutical. I. Choi: Board Member; Self; Hanmi Pharmaceutical." @default.
- W3035227002 created "2020-06-19" @default.
- W3035227002 creator A5017138722 @default.
- W3035227002 creator A5019382914 @default.
- W3035227002 creator A5024610841 @default.
- W3035227002 creator A5030782922 @default.
- W3035227002 creator A5046495384 @default.
- W3035227002 creator A5051779747 @default.
- W3035227002 creator A5054210089 @default.
- W3035227002 creator A5070252558 @default.
- W3035227002 date "2020-06-01" @default.
- W3035227002 modified "2023-10-18" @default.
- W3035227002 title "1830-P: Therapeutic Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in CDHFD-Induced NASH and Fibrosis Mice" @default.
- W3035227002 doi "https://doi.org/10.2337/db20-1830-p" @default.
- W3035227002 hasPublicationYear "2020" @default.
- W3035227002 type Work @default.
- W3035227002 sameAs 3035227002 @default.
- W3035227002 citedByCount "7" @default.
- W3035227002 countsByYear W30352270022020 @default.
- W3035227002 countsByYear W30352270022021 @default.
- W3035227002 countsByYear W30352270022022 @default.
- W3035227002 countsByYear W30352270022023 @default.
- W3035227002 crossrefType "journal-article" @default.
- W3035227002 hasAuthorship W3035227002A5017138722 @default.
- W3035227002 hasAuthorship W3035227002A5019382914 @default.
- W3035227002 hasAuthorship W3035227002A5024610841 @default.
- W3035227002 hasAuthorship W3035227002A5030782922 @default.
- W3035227002 hasAuthorship W3035227002A5046495384 @default.
- W3035227002 hasAuthorship W3035227002A5051779747 @default.
- W3035227002 hasAuthorship W3035227002A5054210089 @default.
- W3035227002 hasAuthorship W3035227002A5070252558 @default.
- W3035227002 hasConcept C126322002 @default.
- W3035227002 hasConcept C134018914 @default.
- W3035227002 hasConcept C170493617 @default.
- W3035227002 hasConcept C2776175330 @default.
- W3035227002 hasConcept C2776954865 @default.
- W3035227002 hasConcept C2777180221 @default.
- W3035227002 hasConcept C2778384471 @default.
- W3035227002 hasConcept C2778772119 @default.
- W3035227002 hasConcept C2778938600 @default.
- W3035227002 hasConcept C2779134260 @default.
- W3035227002 hasConcept C2779478299 @default.
- W3035227002 hasConcept C2780559512 @default.
- W3035227002 hasConcept C2993667909 @default.
- W3035227002 hasConcept C555293320 @default.
- W3035227002 hasConcept C71924100 @default.
- W3035227002 hasConceptScore W3035227002C126322002 @default.
- W3035227002 hasConceptScore W3035227002C134018914 @default.
- W3035227002 hasConceptScore W3035227002C170493617 @default.
- W3035227002 hasConceptScore W3035227002C2776175330 @default.
- W3035227002 hasConceptScore W3035227002C2776954865 @default.
- W3035227002 hasConceptScore W3035227002C2777180221 @default.
- W3035227002 hasConceptScore W3035227002C2778384471 @default.
- W3035227002 hasConceptScore W3035227002C2778772119 @default.
- W3035227002 hasConceptScore W3035227002C2778938600 @default.
- W3035227002 hasConceptScore W3035227002C2779134260 @default.
- W3035227002 hasConceptScore W3035227002C2779478299 @default.
- W3035227002 hasConceptScore W3035227002C2780559512 @default.
- W3035227002 hasConceptScore W3035227002C2993667909 @default.
- W3035227002 hasConceptScore W3035227002C555293320 @default.
- W3035227002 hasConceptScore W3035227002C71924100 @default.
- W3035227002 hasIssue "Supplement_1" @default.
- W3035227002 hasLocation W30352270021 @default.
- W3035227002 hasOpenAccess W3035227002 @default.
- W3035227002 hasPrimaryLocation W30352270021 @default.
- W3035227002 hasRelatedWork W1973843004 @default.
- W3035227002 hasRelatedWork W2038159864 @default.
- W3035227002 hasRelatedWork W2041564399 @default.
- W3035227002 hasRelatedWork W2187035901 @default.
- W3035227002 hasRelatedWork W2411188748 @default.
- W3035227002 hasRelatedWork W2576488295 @default.
- W3035227002 hasRelatedWork W2748242283 @default.
- W3035227002 hasRelatedWork W2914978609 @default.
- W3035227002 hasRelatedWork W3022652730 @default.
- W3035227002 hasRelatedWork W4205938277 @default.
- W3035227002 hasVolume "69" @default.
- W3035227002 isParatext "false" @default.
- W3035227002 isRetracted "false" @default.
- W3035227002 magId "3035227002" @default.
- W3035227002 workType "article" @default.